{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:58:55Z","timestamp":1773680335993,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Novartis Pharma AG","award":["MRLX030_FVMS008"],"award-info":[{"award-number":["MRLX030_FVMS008"]}]},{"DOI":"10.13039\/501100008131","name":"University of Bonn","doi-asserted-by":"publisher","award":["O-109.0052"],"award-info":[{"award-number":["O-109.0052"]}],"id":[{"id":"10.13039\/501100008131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005971","name":"German Heart Foundation","doi-asserted-by":"publisher","award":["K\/14\/16"],"award-info":[{"award-number":["K\/14\/16"]}],"id":[{"id":"10.13039\/501100005971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005971","name":"German Heart Foundation","doi-asserted-by":"publisher","award":["SFB TRR57 P18"],"award-info":[{"award-number":["SFB TRR57 P18"]}],"id":[{"id":"10.13039\/501100005971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ijcard.2017.09.017","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T04:34:13Z","timestamp":1511238853000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties"],"prefix":"10.1016","volume":"250","author":[{"given":"Thomas","family":"Beiert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Knappe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vedat","family":"Tiyerili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"St\u00f6ckigt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Effelsberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Linhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Schierwagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilhelm","family":"Roell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Nickenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan W.","family":"Schrickel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9 P.","family":"Andri\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2017.09.017_bb0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"2013 mortality and causes of death collaborators. Global, regional, and national age\u2013sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the global burden of disease study 2013","volume":"385","author":"GBD","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.09.017_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2009.198","article-title":"Cardiovascular effects of relaxin: from basic science to clinical therapy","volume":"7","author":"Du","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11897-010-0010-z","article-title":"Relaxin: review of biology and potential role in treating heart failure","volume":"7","author":"Teichman","year":"2010","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.HYP.0000171930.00697.2f","article-title":"Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats","volume":"46","author":"Lekgabe","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2017.09.017_bb0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/HYPERTENSIONAHA.114.03594","article-title":"Serelaxin is a more efficacious antifibrotic than enalapril in an experimental model of heart disease","volume":"64","author":"Samuel","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2017.09.017_bb0030","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/labinvest.2010.198","article-title":"Relaxin remodels fibrotic healing following myocardial infarction","volume":"91","author":"Samuel","year":"2011","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0035","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.biopha.2016.09.054","article-title":"Effects of relaxin on cardiac fibrosis, apoptosis, and tachyarrhythmia in rats with myocardial infarction","volume":"84","author":"Wang","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0040","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.atherosclerosis.2016.06.008","article-title":"Anti-atherosclerotic effects of serelaxin in apolipoprotein E-deficient mice","volume":"251","author":"Tiyerili","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2017.09.017_bb0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2017.09.017_bb0050","first-page":"1367","article-title":"Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart","volume":"152","author":"Bani","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.ijcard.2017.09.017_bb0055","first-page":"609","article-title":"Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia\/reperfusion injury via eNOS-dependent mechanism","volume":"113","author":"Valle Raleigh","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0060","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bbrc.2017.06.091","article-title":"Relaxin reduces susceptibility to post-infarct atrial fibrillation in mice due to anti-fibrotic and anti-inflammatory properties","volume":"490","author":"Beiert","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0065","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.hrthm.2015.12.030","article-title":"Relaxin suppresses atrial fibrillation in aged rats by reversing fibrosis and upregulating Na+ channels","volume":"13","author":"Henry","year":"2016","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCRESAHA.113.301646","article-title":"Relaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts","volume":"113","author":"Parikh","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.phrs.2007.11.001","article-title":"Relaxin induces mast cell inhibition and reduces ventricular arrhythmias in a swine model of acute myocardial infarction","volume":"57","author":"Nistri","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1152\/physiolgenomics.00034.2003","article-title":"Implications of ventricular arrhythmia vulnerability during murine electrophysiology studies","volume":"15","author":"Maguire","year":"2003","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.ijcard.2017.09.017_bb0085","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1084\/jem.20061469","article-title":"Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium","volume":"203","author":"Kolossov","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0090","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature06321","article-title":"Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia","volume":"450","author":"Roell","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2017.09.017_bb0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nm.2124","article-title":"Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation","volume":"16","author":"Rudolph","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.yjmcc.2013.09.008","article-title":"The Connexin40A96S mutation from a patient with atrial fibrillation causes decreased atrial conduction velocities and sustained episodes of induced atrial fibrillation in mice","volume":"65","author":"L\u00fcbkemeier","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0105","first-page":"H1906","article-title":"Age-related left ventricular function in the mouse: analysis based on in vivo pressure-volume relationships","volume":"277","author":"Yang","year":"1999","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0110","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1152\/japplphysiol.00033.2007","article-title":"Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches","volume":"102","author":"Takagawa","year":"2007","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/cvr\/cvu046","article-title":"Optogenetic activation of Gq signalling modulates pacemaker activity of cardiomyocytes","volume":"102","author":"Beiert","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1096\/fj.02-0449fje","article-title":"Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis","volume":"17","author":"Samuel","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0125","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/FJC.0b013e318207a35f","article-title":"Fibrosis and cardiac arrhythmias","volume":"57","author":"de Jong","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0130","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1210\/en.2004-0209","article-title":"Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo","volume":"145","author":"Samuel","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2017.09.017_bb0135","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.recesp.2012.03.027","article-title":"Ventricular tachycardia in coronary artery disease","volume":"65","author":"Benito","year":"2012","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00001573-200101000-00001","article-title":"Basic mechanisms of reentrant arrhythmias","volume":"16","author":"Antzelevitch","year":"2001","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fphys.2012.00345","article-title":"Cardiac electrophysiology in mice: a matter of size","volume":"3","author":"Kaese","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0150","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/cphy.c140067","article-title":"Physiological implications of myocardial scar structure","volume":"5","author":"Richardson","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0155","doi-asserted-by":"crossref","first-page":"H1291","DOI":"10.1152\/ajpheart.00111.2005","article-title":"A novel model of cryoinjury-induced myocardial infarction in the mouse: a comparison with coronary artery ligation","volume":"289","author":"van den Bos","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0160","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1248\/bpb.b16-00882","article-title":"Relaxin ameliorates renal fibrosis and expression of endothelial cell transition markers in rats of isoproterenol-induced heart failure","volume":"40","author":"Zheng","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0165","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.2147\/DDDT.S85399","article-title":"Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway","volume":"9","author":"Zhou","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0170","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1582-4934.2011.01328.x","article-title":"Relaxin promotes growth and maturation of mouse neonatal cardiomyocytes in vitro: clues for cardiac regeneration","volume":"16","author":"Nistri","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0175","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.yjmcc.2009.05.008","article-title":"Skeletal myoblasts overexpressing relaxin improve differentiation and communication of primary murine cardiomyocyte cell cultures","volume":"47","author":"Formigli","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0180","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/01.RES.74.3.537","article-title":"Relaxin increases heart rate by modulating calcium current in cardiac pacemaker cells","volume":"74","author":"Han","year":"1994","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0185","first-page":"H1791","article-title":"Effects of relaxin on rat atrial myocytes. I. Inhibition of I(to) via PKA-dependent phosphorylation","volume":"272","author":"Piedras-Renter\u00eda","year":"1997","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0008-6363(01)00434-5","article-title":"The inflammatory response in myocardial infarction","volume":"53","author":"Frangogiannis","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0195","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.trsl.2015.07.002","article-title":"Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges","volume":"167","author":"Saxena","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0200","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1210\/endo.138.11.5520","article-title":"Relaxin counteracts myocardial damage induced by ischemia-reperfusion in isolated guinea pig hearts: evidence for an involvement of nitric oxide","volume":"138","author":"Masini","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijcard.2017.09.017_bb0205","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1096\/fj.04-3664fje","article-title":"Novel drug development opportunity for relaxin in acute myocardial infarction: evidences from a swine model","volume":"19","author":"Perna","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0210","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.tips.2016.04.001","article-title":"Serelaxin: a novel therapeutic for vascular diseases","volume":"37","author":"Leo","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0215","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/bph.12964","article-title":"Serelaxin-mediated signal transduction in human vascular cells: bell-shaped concentration-response curves reflect differential coupling to G proteins","volume":"172","author":"Sarwar","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0220","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1095\/biolreprod.110.089201","article-title":"Relaxin modulates proinflammatory cytokine secretion from human decidual macrophages","volume":"85","author":"Horton","year":"2011","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0225","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1582-4934.2007.00111.x","article-title":"Paracrine effects of transplanted myoblasts and relaxin on post-infarction heart remodelling","volume":"11","author":"Formigli","year":"2007","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijcard.2017.09.017_bb0230","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/ncomms2953","article-title":"Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1","volume":"4","author":"Xiao","year":"2013","journal-title":"Nat. Commun."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317336458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317336458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T19:28:14Z","timestamp":1535225294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317336458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":46,"alternative-id":["S0167527317336458"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.09.017","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}